Allogene Therapeutics hosts CAR T access panel at ASH annual meeting
ALLO•Allogene Therapeutics will host a CAR T access event on Dec. 13, 2026, at the ASH annual meeting in New Orleans, featuring research surveying 152 hematologists and oncologists. A separate showcase hosted by Natera on Dec. 12 will feature the ALPHA3 trial of cema-cel.




